Fundraising Fox

Anne Horgan

Investor

Partner at Cambridge Innovation Capital

Paris, France

Writes $600K – $6M checks · typically $3.3M

About

Anne Horgan blends McKinsey strategy consulting with synthetic organic and medicinal chemistry (PhD Cambridge; Max Planck postdoc; GSK), formalizing university-commercial links via a Clare Hall fellowship and BioIndustry Association board

Invests in

AI & Machine LearningBiotechDeep TechHardwareHealthtechSemiconductors

Experience

  1. Cambridge Innovation CapitalPartnercurrent2021 — present
  2. Advent France BiotechnologyPartner2017 — 2021Paris
  3. Sofinnova PartnersSenior Associate - Life Sciences2016 — 2017Greater Paris Metropolitan Region
  4. Sofinnova PartnersAssociate - Life Sciences2013 — 2015Greater Paris Metropolitan Region
  5. Cancer Research TechnologyBusiness Development Executive2012 — 2013
  6. Cancer Research TechnologyBusiness Development Manager2009 — 2012
  7. Cancer Research TechnologyProject Development Manager2007 — 2009
  8. Cambridge Biotechnology Ltd, a part of the Biovitrum GroupSenior Scientist, Medicinal Chemistry2003 — 2007
  9. Yale UniversityPostdoctoral Fellow2001 — 2002

Education

  1. Yale UniversityPostdoc, Chemistry2001 — 2002
  2. University of BristolPh.D., Synthetic Organic Chemistry1997 — 2001
  3. INSA Rouen NormandieDiplôme d'ingénieur, Chemistry (Chimie Fine et Ingénierie)1992 — 1997

Skills & more

Chemistry9Medicinal Chemistry5Lifesciences15Drug Discovery14R&D8Technology Transfer11Intellectual Property5Organic Chemistry3Biotechnology5Patents2Commercialization3Biochemistry3
+4 moreProtein ChemistryDrug DevelopmentBiopharmaceuticalsPharmaceutical Industry

Languages English · French

From Anne's professional profile.

Same school

Shared employers

Colleagues at Cambridge Innovation Capital

Network5

Investors connected to Anne in public investor directories — a warm-intro map.